CYP2B6*6 allele and age substantially reduce steady‐state ketamine clearance in chronic pain patients: impact on adverse effects

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|80|2|276-284

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.2, 2015-08, pp. : 276-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Age Impact on Expectations and Concerns of Patients Attending a Chronic Pain Clinic?

By  

PAIN PRACTICE, Vol. 18, Iss. 1, 2018-01 ,pp. : 23-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Steady‐State Carbamazepine Pharmacokinetics Following Oral and Stable‐Labeled Intravenous Administration in Epilepsy Patients: Effects of Race and Sex

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 483-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alpha-2-Macroglobulin and Interleukin-6 Levels in Steady-State Sickle Cell Disease Patients

By  

Acta Haematologica, Vol. 104, Iss. 4, 2001-03 ,pp. : 164-168

Karger

Access to resources Recommend Favorite

The Vicious Circle in chronic pain management: balancing efficacy and adverse effects

By Kalso Eija  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 2069-2071

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5‐year study of 51 patients

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 7, 2015-08 ,pp. : 984-993

John Wiley & Sons Inc

Access to resources Recommend Favorite